Long-term foot outcomes following differential abatement of inflammation and osteoclastogenesis for active Charcot neuroarthropathy in diabetes mellitus
<h4>Aims</h4> Inflammatory osteolysis is sine-qua-non of active Charcot neuroarthropathy (CN) causing decreased foot bone mineral density (BMD) and fractures. We aimed to explore the effect of anti-inflammatory or anti-resorptive agents for effect on foot bone mineral content (BMC) and c...
Main Authors: | Liza Das, Ashu Rastogi, Edward B. Jude, Mahesh Prakash, Pinaki Dutta, Anil Bhansali |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2021-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575293/?tool=EBI |
Similar Items
-
Long-term foot outcomes following differential abatement of inflammation and osteoclastogenesis for active Charcot neuroarthropathy in diabetes mellitus.
by: Liza Das, et al.
Published: (2021-01-01) -
Diabetic Foot. Part 2: Charcot Neuroarthropathy
by: Ricardo Cardenuto Ferreira
Published: (2020-09-01) -
CHARCOT NEUROARTHROPATHY
by: Natalia Bertollo, et al.
Published: (2014-04-01) -
An overview of Charcot’s neuroarthropathy
by: Dured Dardari
Published: (2020-12-01) -
The Natural History of Charcot Neuroarthropathy
by: Justin M. Kane MD, et al.
Published: (2016-08-01)